Why should hepatitis C affect immune reconstitution in HIV-1-infected patients?
Graham
C S
CS
Infectious Disease Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Koziel
M J
MJ
D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects; D006526:Hepatitis C / Q000150:complications / Q000276:immunology*; D006801:Humans
D000998:Antiviral Agents